Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Konstantinos P. Imprialos, Konstantinos Stavropoulos, Michael Doumas, Anastasia Skalkou, Ioanna Zografou & Vasilios G. Athyros. (2018) The potential role of statins in treating liver disease. Expert Review of Gastroenterology & Hepatology 12:4, pages 331-339.
Read now
Read now
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher & Amedeo Lonardo. (2018) Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 12:4, pages 351-367.
Read now
Read now
Simona Cernea, Avivit Cahn & Itamar Raz. (2017) Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. Expert Review of Clinical Pharmacology 10:5, pages 535-547.
Read now
Read now
Marco Dioguardi Burgio, Onorina Bruno, Francesco Agnello, Chiara Torrisi, Federica Vernuccio, Giuseppe Cabibbo, Maurizio Soresi, Salvatore Petta, Mauro Calamia, Giovanni Papia, Angelo Gambino, Viola Ricceri, Massimo Midiri, Roberto Lagalla & Giuseppe Brancatelli. (2016) The cheating liver: imaging of focal steatosis and fatty sparing. Expert Review of Gastroenterology & Hepatology 10:6, pages 671-678.
Read now
Read now
Luca Miele & Giovanni Targher. (2015) Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Expert Review of Gastroenterology & Hepatology 9:10, pages 1243-1245.
Read now
Read now
Articles from other publishers (60)
Amedeo Lonardo. (2023) Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies. Exploration of Digestive Diseases, pages 188-201.
Crossref
Crossref
Giandomenico Bisaccia, Fabrizio Ricci, Mohammed Y. Khanji, Anna Sorella, Eugenia Melchiorre, Giovanni Iannetti, Kristian Galanti, Cesare Mantini, Andrea Delli Pizzi, Claudio Tana, Giulia Renda, Artur Fedorowski, Raffaele De Caterina & Sabina Gallina. (2023) Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Current Problems in Cardiology 48:6, pages 101643.
Crossref
Crossref
G. Grzych, L. Bernard, R. Lestrelin, A. Tailleux & B. Staels. (2023) État des lieux sur la physiopathologie, le diagnostic et les traitements de la stéato-hépatite non alcoolique (NASH). Annales Pharmaceutiques Françaises 81:2, pages 183-201.
Crossref
Crossref
Zhao-Chun Chi. (2022) Research status and progress of metabolic associated fatty liver disease. World Chinese Journal of Digestology 30:1, pages 1-16.
Crossref
Crossref
C.M. Schempp. (2022) Die Psoriasis als entzündliche Hauterkrankung zwischen personalisierter Medizin und Anthroposophischer Medizin. Der Merkurstab 75:4, pages 219-225.
Crossref
Crossref
Stanislav Kotlyarov & Aleksei Bulgakov. (2021) Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 10:11, pages 2978.
Crossref
Crossref
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu & Shu-Chi Wang. (2021) The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments. Biomedicines 9:10, pages 1491.
Crossref
Crossref
Rajaa Nahra, Tao Wang, Kishore M. Gadde, Jan Oscarsson, Michael Stumvoll, Lutz Jermutus, Boaz Hirshberg & Philip Ambery. (2021) Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 44:6, pages 1433-1442.
Crossref
Crossref
Huiping Li, Xuena Wang, Mingxu Ye, Shunming Zhang, Qing Zhang, Ge Meng, Li Liu, Hongmei Wu, Yeqing Gu, Yawen Wang, Tingjing Zhang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Yaogang Wang & Kaijun Niu. (2021) Does a high intake of green leafy vegetables protect from NAFLD? Evidence from a large population study. Nutrition, Metabolism and Cardiovascular Diseases 31:6, pages 1691-1701.
Crossref
Crossref
Yi Chia Wu, Philip M. Chuang, Rachel Pinotti, Ankita Nagirimadugu, Nelson Valentin & Amreen Dinani. (2020) The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 33:5, pages 745-751.
Crossref
Crossref
Simona Cernea & Itamar Raz. (2020)
NAFLD
in type 2 diabetes mellitus: Still many challenging questions
. Diabetes/Metabolism Research and Reviews 37:2.
Crossref
Crossref
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher & Amedeo Lonardo. (2021) Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics 11:1, pages 98.
Crossref
Crossref
Ying-Xin Xian, Jian-Ping WengFen Xu. (2021) MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chinese Medical Journal 134:1, pages 8-19.
Crossref
Crossref
Donghee Kim, Luis Miguel Vazquez‐Montesino, Andrew A. Li, George Cholankeril & Aijaz Ahmed. (2020) Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology 72:5, pages 1556-1568.
Crossref
Crossref
Chiara Pisetta, Claudia Chillè, Giovanni Pelizzari, Marie Graciella Pigozzi, Massimo Salvetti, Anna Paini, Maria Lorenza Muiesan, Carolina De Ciuceis, Chiara Ricci & Damiano Rizzoni. (2020) Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. High Blood Pressure & Cardiovascular Prevention 27:4, pages 321-330.
Crossref
Crossref
Amedeo Lonardo & Stefano Ballestri. (2020) Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 1:3, pages 85-107.
Crossref
Crossref
Amedeo Lonardo & Ayako Suzuki. (2020) Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. Journal of Clinical Medicine 9:5, pages 1278.
Crossref
Crossref
Paulina Kur, Agnieszka Kolasa-Wołosiuk, Kamila Misiakiewicz-Has & Barbara Wiszniewska. (2020) Sex Hormone-Dependent Physiology and Diseases of Liver. International Journal of Environmental Research and Public Health 17:8, pages 2620.
Crossref
Crossref
Yan Song, Ying Dang, Ping Wang, Gang Tian & Litao Ruan. (2020) CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness. Journal of Clinical Gastroenterology 54:3, pages 271-277.
Crossref
Crossref
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone & Sabina Gallina. (2020) Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Medicine 8, pages 205031212093380.
Crossref
Crossref
Bahar TEKİN TAK, Serkan ÇAY, Mahmut YÜKSEL, Firdevs Ayşenur EKİZLER, Meral AKDOĞAN AYHAN, Habibe KAFES, Çağrı YAYLA & Ertuğrul KAYAÇETİN. (2019) Tp-e interval and Tp-e/qt ratio in patients with non alcoholic fatty liver diseaseNonalkolik yağlı karaciğer hastalığı olan bireylerde Tp-e intervali ve Tp-e/qt oranı. Turkish Journal of Clinics and Laboratory 10:3, pages 358-363.
Crossref
Crossref
Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra & Zobair M. Younossi. (2019) Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 3:8, pages 1050-1060.
Crossref
Crossref
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi & Amedeo Lonardo. (2019) Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. Atherosclerosis 284, pages 66-74.
Crossref
Crossref
Elisabete Martins & Ana Oliveira. (2018) NAFLD and cardiovascular disease. Porto Biomedical Journal 3:2, pages e2.
Crossref
Crossref
Lauren N. Woodie, Yuwen Luo, Michael J. Wayne, Emily C. Graff, Bulbul Ahmed, Ann Marie O'Neill & Michael W. Greene. (2018) Restricted feeding for 9 h in the active period partially abrogates the detrimental metabolic effects of a Western diet with liquid sugar consumption in mice. Metabolism 82, pages 1-13.
Crossref
Crossref
Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, Enrica Baldelli, Simonetta Lugari, Valentina Sirotti, Valentina Giampaoli & Amedeo Lonardo. (2018) Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?. Diseases 6:1, pages 17.
Crossref
Crossref
Giovanni Targher, Amedeo Lonardo & Christopher D. Byrne. (2017) Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nature Reviews Endocrinology 14:2, pages 99-114.
Crossref
Crossref
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani & Giovanni Targher. (2018) Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 68:2, pages 335-352.
Crossref
Crossref
Peter W.F. Wilson & Christopher J. O’Donnell. 2018. Chronic Coronary Artery Disease. Chronic Coronary Artery Disease
1
15
.
Surasak Saokaew, Shada Kanchanasuwan, Piyaporn Apisarnthanarak, Aphinya Charoensak, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa & Nathorn Chaiyakunapruk. (2017) Clinical risk scoring for predicting non‐alcoholic fatty liver disease in metabolic syndrome patients (NAFLD‐MS score). Liver International 37:10, pages 1535-1543.
Crossref
Crossref
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi & Luigi Elio Adinolfi. (2017) Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 23:36, pages 6571-6592.
Crossref
Crossref
Amedeo Lonardo & Giovanni Targher. (2017) NAFLD: Is There Anything New under the Sun?. International Journal of Molecular Sciences 18:9, pages 1955.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 29:4, pages 185-200.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 29:4, pages 185-200.
Crossref
Crossref
Alessandro Mantovani. (2017) Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis. Journal of Clinical and Translational Hepatology XX:XX, pages 1-8.
Crossref
Crossref
Amedeo Lonardo, Fabio Nascimbeni & Maurizio Ponz de Leon. (2017) Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?. European Respiratory Journal 49:6, pages 1700546.
Crossref
Crossref
Jui-Kun Chiang, Lin Chih-Wen & Yee-Hsin Kao. (2017) Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open 7:6, pages e015936.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli & Amedeo Lonardo. (2017) NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Advances in Therapy 34:6, pages 1291-1326.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular. Clínica e Investigación en Arteriosclerosis 29:3, pages 141-148.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease. Clínica e Investigación en Arteriosclerosis (English Edition) 29:3, pages 141-148.
Crossref
Crossref
N. M. Pimenta, H. Cortez-Pinto, X. Melo, J. Silva-Nunes, L. B. Sardinha & H. Santa-Clara. (2017) Waist-to-height ratio is independently related to whole and central body fat, regardless of the waist circumference measurement protocol, in non-alcoholic fatty liver disease patients. Journal of Human Nutrition and Dietetics 30:2, pages 185-192.
Crossref
Crossref
Amedeo Lonardo, Stefano Ballestri & Giovanni Targher. (2017) “ Not all forms of NAFLD were created equal ”. Do metabolic syndrome-related NAFLD and PNPLA3 -related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?. Atherosclerosis 257, pages 253-255.
Crossref
Crossref
Setor K. Kunutsor. (2016) Gamma-glutamyltransferase-friend or foe within?. Liver International 36:12, pages 1723-1734.
Crossref
Crossref
Veeravich Jaruvongvanich, Kamonkiat Wirunsawanya, Anawin Sanguankeo & Sikarin Upala. (2016) Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis. Digestive and Liver Disease 48:12, pages 1410-1417.
Crossref
Crossref
Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Kiichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui & Yoshito Itoh. (2016) Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease. Hepatology Research 46:11, pages 1107-1117.
Crossref
Crossref
Giovanni Targher, Christopher D. Byrne, Amedeo Lonardo, Giacomo Zoppini & Corrado Barbui. (2016) Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. Journal of Hepatology 65:3, pages 589-600.
Crossref
Crossref
Amedeo Lonardo, Silvia Sookoian, Carlos J. Pirola & Giovanni Targher. (2016) Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65:8, pages 1136-1150.
Crossref
Crossref
Nancy E. Aguilar-Olivos, Paloma Almeda-Valdes, Carlos A. Aguilar-Salinas, Misael Uribe & Nahum Méndez-Sánchez. (2016) The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism 65:8, pages 1196-1207.
Crossref
Crossref
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo & Giovanni Targher. (2016) Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 61:5, pages 1246-1267.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher & Amedeo Lonardo. (2016) Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 17:3, pages 355.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli & Amedeo Lonardo. (2016) The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy 33:3, pages 291-319.
Crossref
Crossref
Alessandro Mantovani, Paolo Gisondi, Amedeo Lonardo & Giovanni Targher. (2016) Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?. International Journal of Molecular Sciences 17:2, pages 217.
Crossref
Crossref
Giovanni Targher, Maurizio Rossini & Amedeo Lonardo. (2015) Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?. Endocrine 51:2, pages 211-221.
Crossref
Crossref
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona & Giovanni Targher. (2016) Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 22:44, pages 9674.
Crossref
Crossref
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele & Giovanni Targher. (2015) Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 47:12, pages 997-1006.
Crossref
Crossref
Ali A. Mencin, Rohit Loomba & Joel E. Lavine. (2015) Caring for children with NAFLD and navigating their care into adulthood. Nature Reviews Gastroenterology & Hepatology 12:11, pages 617-628.
Crossref
Crossref
Ling-Ling Pan, Hui-Jie Zhang, Zhu-Feng Huang, Qian Sun, Zheng Chen, Zhi-Bin Li, Shu-Yu Yang, Xiao-Ying Li & Xue-Jun Li. (2015) Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study. Metabolism 64:9, pages 1077-1085.
Crossref
Crossref
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa & Hiroshi Ito. (2015) Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLOS ONE 10:6, pages e0131138.
Crossref
Crossref
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P Mikhailidis. (2015) Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 21:22, pages 6820-6834.
Crossref
Crossref
Michael Trauner, Emina Halilbasic, Thierry Claudel, Daniel Steinacher, Claudia Fuchs, Tarek Moustafa, Marion Pollheimer, Elisabeth Krones, Christian Kienbacher, Stefan Traussnigg, Lili Kazemi-Shirazi, Petra Munda, Harald Hofer, Peter Fickert & Gustav Paumgartner. (2015) Potential of <b><i>nor</i></b>-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders. Digestive Diseases 33:3, pages 433-439.
Crossref
Crossref